List of centrally authorised products requiring a notification of a change for update of annexes
Clinical Trials Information System (CTIS): Walk-in clinic - May 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 May 2024, 16:00 (CEST) to 15 May 2024, 17:00 (CEST)
IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants
Environmental Risk Assessment (ERA) Assessors Training, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 23 May 2024, 13:00 (CEST) to 24 May 2024, 14:00 (CEST)
Veterinary medicines European public assessment report (EPAR): Strangvac, Streptococcus equi vaccine (recombinant proteins), Status: Authorised
Herbal medicinal product: Rhodiolae roseae rhizoma et radixArray, F: Assessment finalised
Human medicines European public assessment report (EPAR): Zonisamide Mylan, zonisamide, Date of authorisation: 31/03/2016, Revision: 10, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Loxitab, meloxicam, Status: Authorised
Giapreza
Veterinary medicines European public assessment report (EPAR): Eluracat, capromorelin tartrate, Status: Authorised